HIV diversity as a biomarker for hiv incidence estimation: Including a high-resolution melting diversity assay in a multiassay algorithm

Journal of Clinical Microbiology

Volumn 52, Issue 1, 2014, Pages 115-121

  Cousins, Matthew M ^a   Konikoff, Jacob ^b   Laeyendecker, Oliver ^a,c   Celum, Connie ^d   Buchbinder, Susan P ^e,f   Seage, George R ^g   Kirk, Gregory D ^h   Moore, Richard D ^a   Mehta, Shruti H ^h   Margolick, Joseph B ^h   Brown, Joelle ^b   Mayer, Kenneth H ⁱ   Koblin, Beryl A ^j   Wheeler, Darrell ^k   Justman, Jessica E ^l   Hodder, Sally L ^m   Quinn, Thomas C ^a,c   Brookmeyer, Ron ^b   Eshleman, Susan H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e HIV STD and Hepatitis Branch   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j NEW YORK BLOOD CENTER   (United States)

^k LOYOLA UNIVERSITY CHICAGO   (United States)

^l Och Spine at New York Presbyterian Hospitals   (United States)

^m RUTGERS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAG PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ALGORITHM; ARTICLE; ASSAY; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE MARKER; ENZYME IMMUNOASSAY; GENETIC VARIABILITY; HIGH RESOLUTION MELTING DIVERSITY ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MALE; MULTIASSAY ALGORITHM; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SEQUENCE ANALYSIS; VIRUS GENOME; VIRUS LOAD;

ALGORITHMS; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GENETIC VARIATION; HIV; HIV INFECTIONS; HUMANS; IMMUNOASSAY; INCIDENCE; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; TRANSITION TEMPERATURE; UNITED STATES; VIRAL LOAD;

EID: 84891507815     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02040-13     Document Type: Article

References (37)

1. Brookmeyer R. 2010. Measuring the HIV/AIDS epidemic: Approaches and challenges. Epidemiol. Rev. 32:26-37. http://dx.doi.org/10.1093/epirev/mxq002.
2. Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH, Multicenter AIDS Cohort Study MACS. 2012. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res. Hum. Retroviruses 28:816-822. http://dx.doi.org/10.1089/aid.2011.0258.
3. Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH. 2013. Crosssectional HIV incidence estimation in HIV prevention research. J. Acquir. Immune Defic. Syndr. 63(Suppl 2):S233-S239. http://dx.doi.org/10.1097/QAI. 0b013e3182986fdf.
4. Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR, III, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH. 2013. HIV incidence determination in the United States: A multiassay approach. J. Infect. Dis. 207:232-239. http://dx.doi.org/10.1093/infdis/jis659.
5. Laeyendecker O, Rothman RE, Henson C, Horne BJ, Ketlogetswe KS, Kraus CK, Shahan J, Kelen GD, Quinn TC. 2008. The effect of viral suppression on cross-sectional incidence testing in the Johns Hopkins Hospital emergency department. J. Acquir. Immune Defic. Syndr. 48: 211-215. http://dx.doi.org/10. 1097/QAI.0b013e3181743980.
6. Brookmeyer R. 2010. On the statistical accuracy of biomarker assays for HIV incidence. J. Acquir. Immune Defic. Syndr. 54:406-414. http://dx.doi.org/10. 1097/QAI.0b013e3181dc6d2c.
7. Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH. 2013. Estimation of HIV incidence using multiple biomarkers. Am. J. Epidemiol. 177:264-272. http://dx.doi.org/10.1093/aje/kws436.
8. Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, Johnson-Lewis L, Mullis CE, Hackett J, Jr, Vallari AS, Justman J, Hodder S. 2013. Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J. Infect. Dis. 207:223-231. http://dx.doi.org/10.1093/infdis/jis658.
9. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM. 2008. The challenge of HIV-1 subtype diversity. N. Engl. J. Med. 358:1590-1602. http://dx.doi.org/ 10.1056/NEJMra0706737.
10. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS. 2004. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J. Clin. Microbiol. 42:2623-2628. http://dx.doi.org/10.1128/JCM.42.6.2623-2628.2004.
11. Masciotra S, Dobbs T, Candal D, Hanson D, Delaney K, Rudolph D, Charurat M, Harrigan R, McDougal S, Owen M. 2010. Antibody aviditybased assay for identifying recent HIV-1 infections based on Genetic Systems TM 1/2 plus O EIA, abstr 937. 17th Conf. Retrovir. Opportunistic Infect., San Francisco, CA, 16 to 19 February 2010.
12. Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, Hudelson SE, Khaki L, Koblin B, Chesney M, Moore RD, Kelen GD, Coates T, Celum C, Buchbinder SP, Seage GR, III, Quinn TC, Donnell D, Eshleman SH. 2011. Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS One 6:e27211. http://dx.doi.org/10.1371/journal .pone.0027211.
13. Kouyos RD, von Wyl V, Yerly S, Böni J, Rieder P, Joos B, Taffé P, Shah C, Bürgisser P, Klimkait T, Weber R, Hirschel B, Cavassini M, Rauch A, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Bonhoeffer S, Günthard HF, Swiss HIV Cohort Study. 2011. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin. Infect. Dis. 52:532-539. http://dx.doi.org/10.1093/cid/ciq164.
14. Yang J, Xia X, He X, Yang S, Ruan Y, Zhao Q, Wang Z, Shao Y, Pan X. 2012.Anew pattern-based method for identifying recent HIV-1 infections from the viral env sequence. Sci. China Life Sci. 55:328-335. http://dx.doi.org/10.1007/ s11427-012-4312-0.
15. Cousins MM, Swan D, Magaret CA, Hoover DR, Eshleman SH. 2012. Analysis of HIV using a high resolution melting (HRM) diversity assay: Automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidence. PLoS One 7:e51359. http://dx.doi.org/10.1371/journal.pone.0051359.
16. Cousins MM, Donnell D, Eshleman SH. 2013. Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay. J. Mol. Diagn. 15:130-137. http://dx.doi.org/10.1016/j.jmoldx.2012.08.008.
17. Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson JB, Eshleman SH. 2010. Analysis of HIV diversity using a high-resolution melting assay. AIDS Res. Hum. Retroviruses 26:913-918. http://dx.doi.org/10.1089/aid.2009.0259.
18. Cousins MM, Ou SS, Wawer MJ, Munshaw S, Swan D, Magaret CA, Mullis CE, Serwadda D, Porcella SF, Gray RH, Quinn TC, Donnell D, Eshleman SH, Redd AD. 2012. Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity. J. Clin. Microbiol. 50:3054-3059. http://dx.doi.org/10.1128/JCM.01460-12.
19. James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen G, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH. 2013. Antibody maturation and viral diversification in HIV-infected women. PLoS One 8:e57350. http://dx.doi.org/10.1371/journal.pone. 0057350.
20. Laeyendecker O, Brookmeyer R, Kulich M, Quinn T, Konikoff J, Cousins M, Donnell D, Eshleman S. 2013. Accurate cross-sectional HIV incidence testing, abstr 164. 20th Conf. Retrovir. Opportunistic Infect., Atlanta, GA, 3 to 6 March 2013.
21. Laeyendecker O, Wang L, Hughes J, Cummings V, Piwowar-Manning E, Wheeler D, Griffith S, Mayer K, Koblin B, Eshleman SH. 2013. Use of a multi-assay algorithm for cross-sectional HIV incidence estimation in HPTN 061 (the Brothers Study), abstr 1053. 20th Conf. Retrovir. Opportunistic Infect., Atlanta, GA, 3 to 6 March 2013.
22. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR, Jr. 1987. The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants. Am. J. Epidemiol. 126:310-318. http://dx.doi.org/10.1093/aje/126.2.310.
23. Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, Celentano DD, Solomon L, Polk BF. 1991. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants. NIDA Res. Monogr. 109:75-100.
24. Celum C, Buchbinder SP, Donnell D, Douglas JM, Jr, Mayer K, Koblin B, Marmor M, Bozeman S, Grant RM, Flores J, Sheppard HW. 2001. Early human immunodeficiency virus (HIV) infection in the HIV network for prevention trials vaccine preparedness cohort: Risk behaviors, symptoms, and early plasma and genital tract virus load. J. Infect. Dis. 183:23-35. http://dx.doi.org/10.1086/ 317658.
25. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection. AIDS 17:1871-1879. http://dx.doi.org/10. 1097/00002030-200309050-00005.
26. Moore RD. 1998. Understanding the clinical and economic outcomes of HIV therapy: The Johns Hopkins HIV clinical practice cohort. J. Acquir. Immune Defic. Syndr. 17:S38-S41. http://dx.doi.org/10.1097/00042560-199801001-00011.
27. Hodder SL, Justman J, Hughes JP, Wang J, Haley DF, Adimora AA, Del Rio C, Golin CE, Kuo I, Rompalo A, Soto-Torres L, Mannheimer SB, Johnson-Lewis L, Eshleman SH, El-Sadr WM, HIV Prevention Trials Network 064, Women's HIV SeroIncidence Study Team. 2013. HIV acquisition among women from selected areas of the United States: A cohort study. Ann. Intern. Med. 158:10-18. http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00004.
28. Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, del Rio C, Shoptaw S, Magnus M, Buchbinder S, Wilton L, Liu TY, Cummings V, Piwowar-Manning E, Fields SD, Griffith S, Elharrar V, Wheeler D, HPTN 061 Protocol Team. 2013. Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV Prevention Trials Network (HPTN) 061. PLoS One 8:e70413. http://dx.doi.org/10.1371/journal.pone.0070413.
29. Kaplan EH, Brookmeyer R. 1999. Snapshot estimators of recent HIV incidence rates. Oper. Res. 47:29-37. http://dx.doi.org/10.1287/opre .47.1.29.
30. Brookmeyer R. 1997. Accounting for follow-up bias in estimation of human immunodeficiency virus incidence rates. J. R. Stat. Soc. 160:127-140. http://dx.doi.org/10.1111/1467-985X.00049.
31. Ihaka R, Gentleman R. 1996. R: A language for data analysis and graphics. J. Comput. Graph Stat. 5:299-314. http://dx.doi.org/10.2307/1390807.
32. Seage GR, III, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, Marmor M, Woody G, Mayer KH, Stevens C, Judson FN, McKirnan D, Sheon A, Self S, Buchbinder SP. 2001. Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am. J. Epidemiol. 153:619-627. http://dx.doi.org/10.1093/aje/153.7.619.
33. Bar KJ, Li H, Chamberland A, Tremblay C, Routy JP, Grayson T, Sun C, Wang S, Learn GH, Morgan CJ, Schumacher JE, Haynes BF, Keele BF, Hahn BH, Shaw GM. 2010. Wide variation in the multiplicity of HIV-1 infection among injection drug users. J. Virol. 84:6241-6247. http://dx.doi.org/10.1128/JVI.00077-10.
34. Li H, Bar KJ, Wang S, Decker JM, Chen Y, Sun C, Salazar-Gonzalez JF, Salazar MG, Learn GH, Morgan CJ, Schumacher JE, Hraber P, Giorgi EE, Bhattacharya T, Korber BT, Perelson AS, Eron JJ, Cohen MS, Hicks CB, Haynes BF, Markowitz M, Keele BF, Hahn BH, Shaw GM. 2010. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog. 6:e1000890. http://dx.doi.org/10.1371/journal.ppat.1000890.
35. James MM, Wang L, Musoke P, Donnell D, Fogel J, Towler WI, Khaki L, Nakabiito C, Jackson JB, Eshleman SH. 2011. Association of HIV diversity and survival in HIV-infected Ugandan infants. PLoS One 6:e18642. http://dx.doi.org/10.1371/journal.pone.0018642.
36. James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, Fogel JM, Towler WI, Agwu AL, Bagenda D, Mubiru M, Musoke P, Eshleman SH. 2012. Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. Pediatr. Infect. Dis. J. 31:e222-e228. http://dx.doi.org/10.1097/INF. 0b013e3182678c3f.
37. Herrmann MG, Durtschi JD, Wittwer CT, Voelkerding KV. 2007. Expanded instrument comparison of amplicon DNA melting analysis for mutation scanning and genotyping. Clin. Chem. 53:1544-1548. http://dx.doi.org/10.1373/clinchem.2007. 088120.